EMTRIVA, also known by its generic name emtricitabine, is an antiretroviral medication used in the treatment and prevention of HIV/AIDS. It is classified as a nucleoside reverse transcriptase inhibitor (NRTI), which works by inhibiting the action of reverse transcriptase, an enzyme crucial for the replication of HIV. By doing so, EMTRIVA helps to decrease the amount of HIV in the body, allowing the immune system to work better and reducing the likelihood of developing complications related to HIV infection. This medication is often used in combination with other antiretroviral drugs as part of a highly active antiretroviral therapy (HAART) regimen. EMTRIVA is available in capsule form and as an oral solution, making it accessible for adults and children. Its effectiveness, along with a relatively favorable side effect profile, makes it a cornerstone in the management of HIV/AIDS.